Literature DB >> 15451447

Update on herpesvirus amplicon vectors.

Angelika Oehmig1, Cornel Fraefel, Xandra O Breakefield.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15451447     DOI： 10.1016/j.ymthe.2004.06.641

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  20 in total

Review 1.  Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors:  Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal:  Exp Neurol       Date:  2007-08-24       Impact factor: 5.330

Review 2.  Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Authors:  Seung T Lim; Mikko Airavaara; Brandon K Harvey
Journal:  Pharmacol Res       Date:  2009-10-17       Impact factor: 7.658

Review 3.  Genetic therapy for the nervous system.

Authors:  William J Bowers; Xandra O Breakefield; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

Review 4.  Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 5.  Rewiring brain circuits to block cataplexy in murine models of narcolepsy.

Authors:  Meng Liu; Carlos Blanco-Centurion; Priyattam J Shiromani
Journal:  Curr Opin Neurobiol       Date:  2017-04-23       Impact factor: 6.627

6.  Virion-associated cofactor high-mobility group DNA-binding protein-1 facilitates transposition from the herpes simplex virus/Sleeping Beauty amplicon vector platform.

Authors:  Suresh de Silva; Louis T Lotta; Clark A Burris; William J Bowers
Journal:  Hum Gene Ther       Date:  2010-10-07       Impact factor: 5.695

7.  Gene therapy in large animal models of human genetic diseases. Introduction.

Authors:  John H Wolfe
Journal:  ILAR J       Date:  2009

8.  Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.

Authors:  S Prabhakar; G J Brenner; B Sung; S M Messerli; J Mao; M Sena-Esteves; A Stemmer-Rachamimov; B Tannous; X O Breakefield
Journal:  Cancer Gene Ther       Date:  2009-10-16       Impact factor: 5.987

9.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

10.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.